Crossmark

Therapy of high-risk myelodysplastic syndromes

Crossref DOI link: https://doi.org/10.1038/s41409-026-02821-4

Published Online: 2026-03-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ye, Yishan https://orcid.org/0000-0003-3706-4959
Brissot, Eolia https://orcid.org/0000-0003-4471-418X
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
License Information

Text and Data Mining valid from 2026-03-06

Version of Record valid from 2026-03-06
More Information

Article History

Received: 14 January 2026

Revised: 20 January 2026

Accepted: 25 February 2026

First Online: 6 March 2026

Competing interests

: The authors declare no competing interests.